Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Albireo Pharma Inc (ALBO)

Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Albireo Pharma Inc 53 State Street 19th Floor BOSTON MA 02109 USA

www.albireopharma.com P: 857-254-5555

Description:

Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.

Key Statistics

Overview:

Market Capitalization, $K 913,949
Enterprise Value, $K 675,839
Shares Outstanding, K 20,701
Annual Sales, $ 40,580 K
Annual Net Income, $ -34,030 K
Last Quarter Sales, $ 9,830 K
Last Quarter Net Income, $ -37,800 K
60-Month Beta 1.03
% of Insider Shareholders 6.90%
% of Institutional Shareholders 94.25%
Float, K 19,273
% Float 93.10%
Short Volume Ratio 0.10

Growth:

1-Year Return 64.62%
3-Year Return 98.69%
5-Year Return 28.53%
5-Year Revenue Growth 257.22%
5-Year Earnings Growth 54.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.89 on 11/08/22
Latest Earnings Date 03/07/23
Earnings Per Share ttm -6.69
EPS Growth vs. Prev Qtr 7.35%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 11/04/16

ALBO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -97.13%
Return-on-Assets % -46.89%
Profit Margin % -83.86%
Debt/Equity 0.00
Price/Sales 14.98
Price/Cash Flow N/A
Price/Book 8.65
Book Value/Share 5.10
Interest Coverage -1.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar